We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Chips Give Clues to Hirschsprung Disease

By Biotechdaily staff writers
Posted on 16 Oct 2002
Researchers using gene chips, DNA microarrays comprising a minute grid of more than 2,000 characterized DNA bits, have identified two genes linked to Hirschsprung disease, an inherited intestinal disorder. More...
The findings were published September 23, 2002, in the online edition of Nature Genetics.

The investigators, from Johns Hopkins University (Baltimore, MD, USA), studied a group of 43 Old Order Mennonite families. Hirschsprung disease occurs in Mennonite communities in about one out of 500 births, a rate roughly 10 times higher than in the general population.

Employing gene chip technology combined with sophisticated computer analysis, they found susceptibility loci at 10q11, 13q22 and 16q23; the gene at 13q22 is EDNRB, encoding a G protein–coupled receptor (GPCR) and the gene at 10q11 is RET, encoding a receptor tyrosine kinase (RTK). For the clinical disease to be manifested mutations had to be present in both EDNRB and RET.

Two mouse strains were developed, one with RET disrupted and the other with EDNRB disrupted. While neither parental line of mice had intestinal symptoms, breeding the two lines together produced offspring that exhibited conditions more similar to Hirschsprung than any previous attempt to model the disease.

"By tracking thousands of genetic variations passed to affected children by their unaffected parents, we discovered which markers were important in the disease and which ones were not,” explained first author Dr. Minerva Carrasquillo. Exactly how abnormal RET and EDNRB genes coordinate to cause Hirschsprung disease is not yet understood. The proteins encoded by the RET and EDNRB genes are involved in distinct pathways, although some evidence exists of indirect interaction between proteins related to RET and EDNRB. Both RET and EDNRB proteins are involved in connecting nerves to the digestive tract during embryo development.”



Related Links:
Johns Hopkins University

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.